naringenin has been researched along with Parkinsonian Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Afzal, A; Ahmad, S; Batool, Z; Haider, S; Liaquat, L; Madiha, S; Mehdi, BJ; Sadir, S; Sajid, I; Shahzad, S; Tabassum, S | 1 |
Balakrishnan, A; Kannan, RR; Kesh, S | 1 |
Jing, X; Lou, H; Ren, D; Shi, H; Wei, X; Zhang, X | 1 |
3 other study(ies) available for naringenin and Parkinsonian Disorders
Article | Year |
---|---|
Naringenin, a Functional Food Component, Improves Motor and Non-Motor Symptoms in Animal Model of Parkinsonism Induced by Rotenone.
Topics: Animals; Antioxidants; Disease Models, Animal; Functional Food; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Rats; Rotenone | 2023 |
Naringenin alleviates 6-hydroxydopamine induced Parkinsonism in SHSY5Y cells and zebrafish model.
Topics: Animals; Biomarkers; Cell Line; Disease Models, Animal; Flavanones; Humans; Locomotion; Membrane Potential, Mitochondrial; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Zebrafish | 2021 |
Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
Topics: Animals; Antioxidant Response Elements; Apoptosis; Cell Line, Tumor; Corpus Striatum; Dopaminergic Neurons; Flavanones; Humans; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Signal Transduction; Substantia Nigra | 2014 |